Cullin 3 is a protein that in humans is encoded by the CUL3gene. Cullin 3 protein belongs to the family of cullins which in mammals contains eight proteins. Cullin proteins are an evolutionarily conservedfamily of proteins throughout yeast, plants and mammals.
Cullin 3-RING complex consists of Cullin 3 protein, RING-box protein 1, which recruits the ubiquitin-conjugating enzyme, and a Bric-a-brac/Tramtrack/Broad protein, a substrate recognition subunit. Cullin 3 protein is a core scaffold protein coordinating other components of the CRL complex. Cullin 3-RING complexes can also dimerise via their BTB domains which lead to creation of two substrate receptors and two catalytic RING domains. Activation of the complex is regulated by the attachment of the ubiquitin-like proteinNEDD8 to a conserved Lys residue in the cullin-homology domain, the process called neddylation. Deneddylation is conducted by an eight-subunit CSN complex which mediates the cleavage of the isopeptidic bond between NEDD8 and cullin protein. Another protein that interacts with cullin is CAND1 which binds to deneddylated form of cullin protein and disrupts the interaction between cullin and other subunits of the complex leading to inhibition of the E3 ubiquitin ligase activity. Therefore, dynamic neddylation and deneddylation of cullin is important for regulation of CRL complex activity.
Clinical significance
Familial hyperkalemic hypertension
Mutations in CUL3 gene are associated with Familial hyperkalemic hypertension disease. CRL complex containing Cullin 3 controls the activity of Na+ Cl− cotransporter in the kidney by regulating the proteasomal degradation of With-no-lysine kinases WNK1 and WNK4. It was shown that mutations in CUL3 gene lead to WNKs accumulation. The abundance of these kinases leads to increased phosphorylation of NCC and its activation. As a consequence, Na+ reabsorption is increasing resulting in high blood pressure.
Cancer
Deregulation of Cullin 3 expression level was observed in human cancers. It was shown that Cullin 3 is overexpressed in invasive cancers, and the protein expression level positively correlates with tumour stage. In breast cancer, the overexpression of Cullin 3 protein results in a decrease of Nrf2 protein level. This protein is a transcription factor regulating the expression of some detoxification and antioxidant enzymes. Another substrate of CRL complex is a candidate tumour suppressor protein RhoBTB2.